PROMETHAZINE Drug Patent Profile
✉ Email this page to a colleague
When do Promethazine patents expire, and what generic alternatives are available?
Promethazine is a drug marketed by Cenci, Slate Run Pharma, Abbott, Am Regent, Bedford Labs, Epic Pharma Llc, Hospira, Marsam Pharms Llc, Mylan Institutional, Sandoz, Teva Pharms Usa, Watson Labs, West-ward Pharms Int, Wockhardt, Xgen Pharms, Able, Annora Pharma, Cosette, Padagis Israel, Taro, Watson Labs Inc, Amneal Pharms, Chartwell Rx, Kv Pharm, Nostrum Labs Inc, Pharm Assoc, Quagen, Tris Pharma Inc, Whiteworth Town Plsn, Amneal Pharms Ny, Aurobindo Pharma Usa, Chartwell Molecular, Impax Labs, Invatech, Ivax Sub Teva Pharms, Kvk Tech, Prinston Inc, Pvt Form, Strides Pharma, Sun Pharm Inds Inc, Sun Pharm Industries, Tablicaps, Teva, Zydus Pharms Usa, Actavis Mid Atlantic, Hikma, Wockhardt Bio Ag, Ani Pharms, and Xttrium Labs Inc. and is included in one hundred NDAs.
The generic ingredient in PROMETHAZINE is codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride profile page.
Summary for PROMETHAZINE
US Patents: | 0 |
Applicants: | 49 |
NDAs: | 100 |
Raw Ingredient (Bulk) Api Vendors: | 58 |
Clinical Trials: | 58 |
Patent Applications: | 4,296 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PROMETHAZINE |
Drug Sales Revenues: | Drug sales revenues for PROMETHAZINE |
DailyMed Link: | PROMETHAZINE at DailyMed |
Recent Clinical Trials for PROMETHAZINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Trauma Center | N/A |
Oman Medical Speciality Board | Phase 3 |
Tanta University | N/A |